Treatment of cancer cells expressing wild type TP53 with nutlins stabilizes TP53 and activates the TP53 pathway leading to activation of TP53 target genes, cell cycle arrest, apoptosis and/or senescence. The gene discussed is TP53; the disease is cancer.